• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荧光素泪膜破裂时间评估在干眼症患者泪液替代治疗中的疗效:系统评价和荟萃分析。

Fluorescein-tear breakup time as an assessment of efficacy of tear replacement therapy in dry eye patients: a systematic review and meta-analysis.

机构信息

Department of Vision Sciences, Glasgow-Caledonian University, Glasgow, UK.

出版信息

Ocul Surf. 2014 Apr;12(2):100-11. doi: 10.1016/j.jtos.2013.11.002. Epub 2013 Dec 28.

DOI:10.1016/j.jtos.2013.11.002
PMID:24725322
Abstract

PURPOSE

To review outcomes of studies where fluorescein-tear breakup time (fTBUT) measurements had been made before and after treatment with artificial tears.

METHODS

Peer-reviewed articles were identified that reported average values for fTBUT before and after approximately 1 month of treatment of dry eye with aqueous-based artificial tears. 48 data sets were used for calculating the net (percentage) change in fTBUT, with 21 including information of variability (as reported SD of average value) of the fTBUT data suitable for a meta-analysis.

RESULTS

Prior to treatment, average fTBUT values ranged from 0.9 s to 11.8 s (group mean 4.7 +/- 1.7 s, n = 48 data sets). After treatment, these values ranged from 2.2 to 10.7 s (group mean 6.1 +/- 2.3 s; P<.001), with net increase for the treatment effect being 1.4 +/- 1.2 s (range - 1.4 to + 4.5 s). Similar changes were reported regardless of the type of product type. The meta-analysis confirmed a net effect at 1.3 s, with the magnitude of the variability (as a weighted SE) having a similar overall value of 1.1 s.

CONCLUSIONS

Following use of 'artificial tears' by dry eye patients, a small but predictable increase in tear film stability has generally been reported, the net magnitude of which is close to a 33% improvement.

摘要

目的

回顾使用人工泪液治疗干眼症前后进行荧光素泪膜破裂时间(fTBUT)测量的研究结果。

方法

确定了已发表的同行评审文章,这些文章报告了使用基于水的人工泪液治疗干眼症约 1 个月后 fTBUT 的平均数值。使用了 48 个数据集来计算 fTBUT 的净(百分比)变化,其中 21 个数据集包括 fTBUT 数据的可变性(如平均数值的报道 SD)信息,适合进行荟萃分析。

结果

治疗前,平均 fTBUT 值范围为 0.9 秒至 11.8 秒(组平均值 4.7 +/- 1.7 秒,n = 48 个数据集)。治疗后,这些值的范围为 2.2 秒至 10.7 秒(组平均值 6.1 +/- 2.3 秒;P<.001),治疗效果的净增加为 1.4 +/- 1.2 秒(范围 - 1.4 至 + 4.5 秒)。无论产品类型如何,都报告了类似的变化。荟萃分析证实了 1.3 秒的净效应,其可变性(作为加权 SE)的大小具有相似的总体值 1.1 秒。

结论

干眼症患者使用“人工泪液”后,通常报告泪膜稳定性有较小但可预测的增加,其净幅度接近 33%的改善。

相似文献

1
Fluorescein-tear breakup time as an assessment of efficacy of tear replacement therapy in dry eye patients: a systematic review and meta-analysis.荧光素泪膜破裂时间评估在干眼症患者泪液替代治疗中的疗效:系统评价和荟萃分析。
Ocul Surf. 2014 Apr;12(2):100-11. doi: 10.1016/j.jtos.2013.11.002. Epub 2013 Dec 28.
2
Autologous serum eye drops for dry eye.用于干眼症的自体血清眼药水。
Cochrane Database Syst Rev. 2017 Feb 28;2(2):CD009327. doi: 10.1002/14651858.CD009327.pub3.
3
Over the counter (OTC) artificial tear drops for dry eye syndrome.用于干眼症的非处方(OTC)人工泪液滴眼液。
Cochrane Database Syst Rev. 2016 Feb 23;2(2):CD009729. doi: 10.1002/14651858.CD009729.pub2.
4
Autologous serum eye drops for dry eye.用于干眼症的自体血清眼药水。
Cochrane Database Syst Rev. 2013 Aug 27;8(8):CD009327. doi: 10.1002/14651858.CD009327.pub2.
5
Punctal occlusion for dry eye syndrome.用于干眼症的泪点闭塞术。
Cochrane Database Syst Rev. 2017 Jun 26;6(6):CD006775. doi: 10.1002/14651858.CD006775.pub3.
6
Topical corticosteroids for dry eye.局部皮质类固醇治疗干眼。
Cochrane Database Syst Rev. 2022 Oct 21;10(10):CD015070. doi: 10.1002/14651858.CD015070.pub2.
7
Safety and efficacy of rebamipide compared to artificial tears for the treatment of dry eye: a systematic review and meta-analysis.瑞巴派特与人工泪液治疗干眼症的安全性和有效性比较:一项系统评价和荟萃分析。
BMC Ophthalmol. 2025 May 27;25(1):317. doi: 10.1186/s12886-025-04146-0.
8
Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis. topical 药物干预与安慰剂治疗流行性角膜结膜炎的疗效比较。
Cochrane Database Syst Rev. 2022 Mar 3;3(3):CD013520. doi: 10.1002/14651858.CD013520.pub2.
9
Systemic secukinumab treatment in patients with ankylosing spondylitis: the relationship between systemic and tear proinflammatory cytokines and ocular surface findings-a pilot study.强直性脊柱炎患者的司库奇尤单抗全身治疗:全身与泪液促炎细胞因子之间的关系及眼表表现——一项试点研究
Clin Rheumatol. 2025 May 20. doi: 10.1007/s10067-025-07492-y.
10
Short-term Efficacy and Safety of Biological Tear Substitutes and Topical Secretagogues for Dry Eye Disease: A Systematic Review and Network Meta-analysis.短期疗效和安全性的生物泪液替代品和局部促泌剂治疗干眼:系统评价和网络荟萃分析。
Cornea. 2022 Sep 1;41(9):1137-1149. doi: 10.1097/ICO.0000000000002943. Epub 2021 Dec 20.

引用本文的文献

1
Adjunct Topical Human Immunoglobulin IgG Therapy in Dry Eye Disease.辅助性局部用人免疫球蛋白IgG治疗干眼病
Indian J Ophthalmol. 2025 Apr 1;73(4):610-620. doi: 10.4103/IJO.IJO_608_25. Epub 2025 Mar 27.
2
Dry eye in the upper blepharoplasty patient: a study comparing orbicularis-sparing versus orbicularis-excising techniques.上睑成形术患者的干眼症:比较保留眼轮匝肌与切除眼轮匝肌技术的研究。
Graefes Arch Clin Exp Ophthalmol. 2023 Dec;261(12):3625-3634. doi: 10.1007/s00417-023-06131-z. Epub 2023 Jun 24.
3
Solving STODS-Surgical Temporary Ocular Discomfort Syndrome.
解决STODS——手术性暂时性眼部不适综合征
Diagnostics (Basel). 2023 Feb 22;13(5):837. doi: 10.3390/diagnostics13050837.
4
A randomized multicenter evaluation of the efficacy of 0.15% hyaluronic acid versus 0.05% cyclosporine A in dry eye syndrome.一项随机多中心评估 0.15%透明质酸与 0.05%环孢素 A 在干眼症综合征中的疗效。
Sci Rep. 2022 Nov 4;12(1):18737. doi: 10.1038/s41598-022-21330-0.
5
The Association between Preoperative Dry Eye Symptoms and Postoperative Discomfort in Patients Underwent Photorefractive Keratectomy.接受准分子激光角膜切削术患者术前干眼症状与术后不适之间的关联
J Ophthalmol. 2019 Feb 18;2019:7029858. doi: 10.1155/2019/7029858. eCollection 2019.
6
Reliability of the Evidence Addressing Treatment of Corneal Diseases: A Summary of Systematic Reviews.评估角膜疾病治疗方法的证据的可靠性:系统评价综述。
JAMA Ophthalmol. 2019 Jul 1;137(7):775-785. doi: 10.1001/jamaophthalmol.2019.1063.
7
Effect of Proparacaine 0.375%-Sodium Fluorescein 0.25% Eye Drop Mixture and Fluorescein Strip on Anterior Segment Parameters.0.375%丙美卡因-0.25%荧光素钠滴眼液混合物及荧光素试纸对眼前节参数的影响
J Ophthalmol. 2018 Sep 5;2018:5926508. doi: 10.1155/2018/5926508. eCollection 2018.
8
Real-life results of switching from preserved to preservative-free artificial tears containing hyaluronate in patients with dry eye disease.干眼症患者从含防腐剂的人工泪液转换为含透明质酸的无防腐剂人工泪液的实际效果。
Clin Ophthalmol. 2018 Aug 23;12:1519-1525. doi: 10.2147/OPTH.S160053. eCollection 2018.
9
Comparative study of 0.1% hyaluronic acid versus 0.5% carboxymethylcellulose in patients with dry eye associated with moderate keratitis or keratoconjunctivitis.0.1%透明质酸与0.5%羧甲基纤维素治疗伴有中度角膜炎或角膜结膜炎的干眼症患者的对比研究
Clin Ophthalmol. 2018 Jun 11;12:1081-1088. doi: 10.2147/OPTH.S161578. eCollection 2018.
10
[Novel current and future therapy options for treatment of dry eye disease].[治疗干眼症的新型当前及未来治疗选择]
Ophthalmologe. 2018 Feb;115(2):100-106. doi: 10.1007/s00347-017-0608-6.